Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;12(5):e1251.
doi: 10.1002/prp2.1251.

Hypothalamic cannabinoid signaling: Consequences for eating behavior

Affiliations
Review

Hypothalamic cannabinoid signaling: Consequences for eating behavior

Magen N Lord et al. Pharmacol Res Perspect. 2024 Oct.

Abstract

In parallel to the legalization of cannabis for both medicinal and recreational purposes, cannabinoid use has steadily increased over the last decade in the United States. Cannabinoids, such as tetrahydrocannabinol and anandamide, bind to the central cannabinoid-1 (CB1) receptor to impact several physiological processes relevant for body weight regulation, including appetite and energy expenditure. The hypothalamus integrates peripheral signals related to energy balance, houses several nuclei that orchestrate eating, and expresses the CB1 receptor. Herein we review literature to date concerning cannabinergic action in the hypothalamus with a specific focus on eating behaviors. We highlight hypothalamic areas wherein researchers have focused their attention, including the lateral, arcuate, paraventricular, and ventromedial hypothalamic nuclei, and interactions with the hormone leptin. This review serves as a comprehensive analysis of what is known about cannabinoid signaling in the hypothalamus, highlights gaps in the literature, and suggests future directions.

Keywords: CB1 receptor; endocannabinoid; energy balance; feeding; food intake; hedonic; homeostatic; leptin.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts to disclose.

References

    1. Devane WA, Hanuš L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946‐1949. - PubMed
    1. Felder CC, Nielsen A, Briley EM, et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 1996;393(2‐3):231‐235. - PubMed
    1. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long‐term potentiation. Nature. 1997;388(6644):773‐778. - PubMed
    1. Woodhams SG, Sagar DR, Burston JJ, Chapman V. The role of the endocannabinoid system in pain. Handb Exp Pharmacol. 2015;227:119‐143. - PubMed
    1. Kesner AJ, Lovinger DM. Cannabinoids, endocannabinoids and sleep. Front Mol Neurosci. 2020;13:125. - PMC - PubMed

LinkOut - more resources